Resting pulmonary function and artery pressure and cardiopulmonary exercise testing in chronic heart failure patients in Taiwan − a prospective observational cross-sectional study comparing healthy subjects and interstitial lung disease patients

References

• Agostoni P, Bussotti M, Cattadori G, et al. Gas diffusion and alveolar-capillary unit in chronic heart failure. Eur Heart J. 2006;27(21):1–11. doi: 10.1093/eurheartj/ehl302.
   PubMed Web of Science ®Google Scholar
• Van Iterson EH, Cho L, Tonelli A, et al. All-cause mortality predicted by peak oxygen uptake differs depending on spirometry pattern in patients with heart failure and reduced ejection fraction. ESC Heart Fail. 2021;8(4):2731–2740. doi: 10.1002/ehf2.13342.
   PubMed Web of Science ®Google Scholar
• Silvestre OM, Nadruz W, Jr.Querejeta Roca G, et al. Declining lung function and cardiovascular risk: the ARIC study. J Am Coll Cardiol. 2018;72(10):1109–1122. doi: 10.1016/j.jacc.2018.06.049.
   PubMed Web of Science ®Google Scholar
• Faisal A;Alghamdi BJ, Ciavaglia CE, Elbehairy AF, et al. Common mechanisms of dyspnea in chronic interstitial and obstructive lung disorders. Am J Respir Crit Care Med. 2016;193(3):299–309. doi: 10.1164/rccm.201504-0841OC.
   PubMed Web of Science ®Google Scholar
• Mancini DM, Henson D, LaManca J, et al. Respiratory muscle function and dyspnea in patients with chronic congestive heart failure. Circulation. 1992;86(3):909–918. doi: 10.1161/01.cir.86.3.909.
   PubMed Web of Science ®Google Scholar
• Hawkins NM, Petrie MC, Jhund PS, et al. Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology. Eur J Heart Fail. 2009;11(2):130–139. doi: 10.1093/eurjhf/hfn013.
   PubMed Web of Science ®Google Scholar
• Olson TP, Beck KC, Johnson BD. Pulmonary function changes associated with cardiomegaly in chronic heart failure. J Card Fail. 2007;13(2):100–107. doi: 10.1016/j.cardfail.2006.10.018.
   PubMed Web of Science ®Google Scholar
• Daganou M, Dimopoulou I, Alivizatos PA, et al. Pulmonary function and respiratory muscle strength in chronic heart failure: comparison between ischaemic and idiopathic dilated cardiomyopathy. Heart. 1999;81(6):618–620. doi: 10.1136/hrt.81.6.618.
   PubMed Web of Science ®Google Scholar
• Cross TJ, Sabapathy S, Beck KC, et al. The resistive and elastic work of breathing during exercise in patients with chronic heart failure. Eur Respir J. 2012;39(6):1449–1457. doi: 10.1183/09031936.00125011.
   PubMed Web of Science ®Google Scholar
• Gille T, Laveneziana P. Cardiopulmonary exercise testing in interstitial lung diseases and the value of ventilatory efficiency. Eur Respir Rev. 2021;30(162):200355. doi: 10.1183/16000617.0355-2020.
   PubMed Web of Science ®Google Scholar
• Wasserman K, Zhang YY, Gitt A, et al. Lung function and exercise gas exchange in chronic heart failure. Circulation. 1997;96(7):2221–2227. doi: 10.1161/01.cir.96.7.2221.
   PubMed Web of Science ®Google Scholar
• Johnson BD, Beck KC, Olson LJ, et al. Ventilatory constraints during exercise in patients with chronic heart failure. Chest. 2000;117(2):321–332. doi: 10.1378/chest.117.2.321.
   PubMed Web of Science ®Google Scholar
• Marciniuk DD, Sridhar G, Clemens RE, et al. Lung volumes and expiratory flow limitation during exercise in interstitial lung disease. J Appl Physiol. 1994;77(2):263–273.
   Web of Science ®Google Scholar
• Stubbing DG, Pengelly LD, Morse JL, et al. Pulmonary mechanics during exercise in normal males. J Appl Physiol Respir Environ Exerc Physiol. 1980;49(3):506–510. doi: 10.1152/jappl.1980.49.3.506.
   PubMed Web of Science ®Google Scholar
• Wasserman K, Hansen JE, Sue DY, et al. Principles of interpretation: a flowchart approach. In: Wasserman K, ­editor. Principles of exercise testing and interpretation. 4th edition. Philadelphia: Lippincot Williams & Wilkins; 2005. p. 183–197.
   Google Scholar
• Contini M, Conte E, Agostoni P. Lung function evaluation in heart failure: possible pitfalls. Breathe. 2020;16(1):190316. doi: 10.1183/20734735.0316-2019.
   Web of Science ®Google Scholar
• Kovacs G, Dumitrescu D, Barner A, et al. Definition, clinical classification and initial diagnosis of pulmonary hypertension: updated recommendations from the cologne consensus conference 2018. Int J Cardiol. 2018;272S:11–19. doi: 10.1016/j.ijcard.2018.08.083.
   PubMedGoogle Scholar
• Agostoni P, Magini A, Andreini D, et al. Spironolactone improves lung diffusion in chronic heart failure. Eur Heart J. 2005;26(2):159–164. doi: 10.1093/eurheartj/ehi023.
   PubMed Web of Science ®Google Scholar
• Guazzi M, Ghio S, Adir Y. Pulmonary hypertension in HFpEF and HFrEF: JACC review topic of the week. J Am Coll Cardiol. 2020;76(9):1102–1111. doi: 10.1016/j.jacc.2020.06.069.
   PubMed Web of Science ®Google Scholar
• Berthelot E, Bauer F, Eicher JC, et al. Pulmonary hypertension in chronic heart failure: definitions, advances, and unanswered issues. ESC Heart Fail. 2018;5(5):755–763. doi: 10.1002/ehf2.12316.
   PubMed Web of Science ®Google Scholar
• Jellis CL, Park MM, Abidov A, et al. Comprehensive echocardiographic evaluation of the right heart in patients with pulmonary vascular diseases: the PVDOMICS experience. Eur Heart J Cardiovasc Imaging. 2022;23(7):958–969. doi: 10.1093/ehjci/jeab065.
   PubMed Web of Science ®Google Scholar
• Reddy YNV, Obokata M, Koepp KE, et al. The beta-Adrenergic agonist albuterol improves pulmonary vascular reserve in heart failure with preserved ejection fraction. Circ Res. 2019;124(2):306–314. doi: 10.1161/CIRCRESAHA.118.313832.
   PubMed Web of Science ®Google Scholar
• Sugimoto T, Bandera F, Generati G;Alfonzetti E, et al. Left atrial dynamics during exercise in mitral regurgitation of primary and secondary origin: pathophysiological insights by exercise echocardiography combined with gas exchange analysis. JACC Cardiovasc Imaging. 2020;13(1 Pt 1):25–40. doi: 10.1016/j.jcmg.2018.12.031.
   PubMed Web of Science ®Google Scholar
• Miller WL, Grill DE, Borlaug BA. Clinical features, hemodynamics, and outcomes of pulmonary hypertension due to chronic heart failure with reduced ejection fraction: pulmonary hypertension and heart failure. JACC Heart Fail. 2013;1(4):290–299. doi: 10.1016/j.jchf.2013.05.001.
   PubMed Web of Science ®Google Scholar
• Dickstein K, Cohen-Solal A;Filippatos G, McMurray JJV, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 the task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the heart failure association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Europ Heart J. 2008;29(19):2388–2442.
   PubMed Web of Science ®Google Scholar
• Du Bois RM Wells, AU The lungs and connective tissue diseases. In: Manson RJ, Broaddus VCJF, Nadel JA, editors. Murray and Nadel’s textbook of respiratory medicine. Volume 2 Philadelphia: Elsevir Saunders; 2005. p. 1609–1633.
   Google Scholar
• King TE Schwarz, MI Approach to diagnosis and management of the idiopathic interstitial pneumonitis. In: Manson RJVCJF, Nadel JA, editors. Murray and Nadel’s textbook of respiratory medicine. Philadelphia: Elsevir Saunders; 2005. p. 1571–1608.
   Google Scholar
• Chuang ML, Tsai CF, Ueng KC, et al. The impact of oxygen pulse and its curve patterns on male patients with heart failure, chronic obstructive pulmonary disease, and healthy controls—ejection fractions, related factors and outcomes. JPM. 2022;12(5):703. doi: 10.3390/jpm12050703.
   Google Scholar
• Rudski LG, Lai WW, Afilalo J, et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr. 2010;23(7):685–713. doi: 10.1016/j.echo.2010.05.010.
   PubMed Web of Science ®Google Scholar
• Chuang ML, Lin IF. Investigating the relationships among lung function variables in chronic obstructive pulmonary disease in men. Peer J. 2019;7:e7829. doi: 10.7717/peerj.7829.
   PubMed Web of Science ®Google Scholar
• Chuang ML, Lin IF, Wasserman K. The body weight-walking distance product as related to lung function, anaerobic threshold and peak VO2 in COPD patients. Respir Med. 2001;95(7):618–626. doi: 10.1053/rmed.2001.1115.
   PubMed Web of Science ®Google Scholar
• Wasserman K, Hansen JE, Sue DY, et al. Clinical exercise testing. In: Wasserman K, editor. Principles of exercise testing and interpretation. 4th edition. Philadelphia: Lippicott Williams & Wilkins; 2005. p. 133–159.
   Google Scholar
• Chuang ML, Lee CH, Lin IF. Using the oxygen-cost diagram in ramp-slope selection for dyspneic patients. Intern Med. 2010;49(14):1325–1332. doi: 10.2169/internalmedicine.49.3094.
   PubMed Web of Science ®Google Scholar
• Chuang M-L, Hsieh M-J, Wu T-C, et al. Developing a new marker of dynamic hyperinflation in patients with obstructive airway disease – an observational study. Sci Rep. 2019;9(1):7514. doi: 10.1038/s41598-019-43893-1.
   PubMedGoogle Scholar
• The Committee: this Joint Statement of the ATS and the ACCP was adopted by the ATS Board of Directors, March 1, 2002 and by the ACCP Health Science Policy Committee, November 1, 2001. ATS/ACCP statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med. 2003;167(2):211–277.
   PubMed Web of Science ®Google Scholar
• Chuang ML, Lin IF. Clinical characteristics and lung function in chronic obstructive pulmonary disease complicated with impaired peripheral oxygenation. Intern Emerg Med. 2014;9(6):633–640. doi: 10.1007/s11739-013-0989-8.
   PubMed Web of Science ®Google Scholar
• Chuang ML, Huang SF, Su CH. Cardiovascular and respiratory dysfunction in chronic obstructive pulmonary disease complicated by impaired peripheral oxygenation. Int J Chron Obstruct Pulmon Dis. 2015;10(:329–337. doi: 10.2147/COPD.S76209.
   PubMed Web of Science ®Google Scholar
• Radtke T, Crook S, Kaltsakas G, et al. ERS statement on standardisation of cardiopulmonary exercise testing in chronic lung diseases. Eur Respir Rev. 2019;28(154):180101. doi: 10.1183/16000617.0101-2018.
   PubMed Web of Science ®Google Scholar
• Guenette JA, Chin RC, Cory JM, et al. Inspiratory capacity during exercise: measurement, analysis, and interpretation. Pulm Med. 2013;2013:956081. doi: 10.1155/2013/956081.
   PubMedGoogle Scholar
• Chuang ML, Lin IF, Lee CY. Clinical assessment tests in evaluating patients with chronic obstructive pulmonary disease – a cross-sectional study. Medicine. 2016;95(47):e5471. doi: 10.1097/MD.0000000000005471.
   PubMed Web of Science ®Google Scholar
• Guazzi M, Borlaug BA. Pulmonary hypertension due to left heart disease. Circulation. 2012;126(8):975–990. doi: 10.1161/CIRCULATIONAHA.111.085761.
   PubMed Web of Science ®Google Scholar
• Guazzi M, Naeije R. Pulmonary hypertension in heart failure: pathophysiology, pathobiology, and emerging clinical perspectives. J Am Coll Cardiol. 2017;69(13):1718–1734. doi: 10.1016/j.jacc.2017.01.051.
   PubMed Web of Science ®Google Scholar
• Agostoni P, Cattadori G, Guazzi M, et al. Cardiomegaly as a possible cause of lung dysfunction in patients with heart failure. Am Heart J. 2000;140(5):e24. doi: 10.1067/mhj.2000.110282.
   PubMedGoogle Scholar
• Guazzi M. Alveolar-capillary membrane dysfunction in heart failure: evidence of a pathophysiologic role. Chest. 2003;124(3):1090–1102. doi: 10.1378/chest.124.3.1090.
   PubMed Web of Science ®Google Scholar
• Puri S, Baker BL, Dutka DP, et al. Reduced alveolar-capillary membrane diffusing capacity in chronic heart failure. Its pathophysiological relevance and relationship to exercise performance. Circulation. 1995;91(11):2769–2774. doi: 10.1161/01.cir.91.11.2769.
   PubMed Web of Science ®Google Scholar
• Apostolo A, Giusti G, Gargiulo P, et al. Lungs in heart failure. Pulm Med. 2012;2012:952741. doi: 10.1155/2012/952741.
   PubMedGoogle Scholar
• Mancini DM, Ferraro N, Nazzaro D, et al. Respiratory muscle deoxygenation during exercise in patients with heart failure demonstrated with near-infrared spectroscopy. J Am Coll Cardiol. 1991;18(2):492–498. doi: 10.1016/0735-1097(91)90605-9.
   PubMed Web of Science ®Google Scholar
• Seeger W, Adir Y, Barbera JA, et al. Pulmonary hypertension in chronic lung diseases. J Am Coll Cardiol. 2013;62(25 Suppl):D109–116. doi: 10.1016/j.jacc.2013.10.036.
   PubMed Web of Science ®Google Scholar
• Chuang ML, Lin IF, Hsieh MJ. More impaired dynamic ventilatory muscle oxygenation in congestive heart failure than in chronic obstructive pulmonary disease. JCM. 2019;8(10):1641. doi: 10.3390/jcm8101641.
   Google Scholar
• Keir GJ, Wort SJ, Kokosi M, et al. Pulmonary hypertension in interstitial lung disease: limitations of echocardiography compared to cardiac catheterization. Respirology. 2018;23(7):687–694. doi: 10.1111/resp.13250.
   PubMed Web of Science ®Google Scholar
• Kapella-Mshigeni S, Kimunai E, Cross CL. The prevalence rate of cigarette smoking among congestive heart failure patients at a local family health center. Ann Public Health Rep. 2019;3(1):30–34.
   Google Scholar
• Kiakouama L, Cottin V, Glerant JC, et al. Conditions associated with severe carbon monoxide diffusion coefficient reduction. Respir Med. 2011;105(8):1248–1256. doi: 10.1016/j.rmed.2011.03.004.
   PubMed Web of Science ®Google Scholar
• Lin H, Jiang S. Combined pulmonary fibrosis and emphysema (CPFE): an entity different from emphysema or pulmonary fibrosis alone. J Thorac Dis. 2015;7(4):767–779. doi: 10.3978/j.issn.2072-1439.2015.04.17.
   PubMed Web of Science ®Google Scholar